Fundraising Fox

Concentric Analgesics

Los Altos, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

JF
John F. DonovanExecutive
FJ
Frank J. BellizziExecutive

Board

CH
Craig HusfeldBoard director

Investors · 1

Kern Capital, LLCLarkspur · $5M – $15Mvia Jay Kern · inferred

Reported raises · per SEC filings

Form D private placements

$130.8M disclosed across 5 rounds · 2016–2021

▶$20MraisedDec 2021 · 116 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John F. DonovanExecutive Officer, Director
  • Frank J. BellizziExecutive Officer, Director
  • Thomas KingExecutive Officer, Director
Offering amount
$40M
Amount sold
$20M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$77.1MraisedMay 2019 · 144 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank J. BellizziExecutive Officer, Director
  • Larry FeinbergDirector
  • Thomas KingExecutive Officer, Director
  • John F. DonovanExecutive Officer, Director
Offering amount
$77.1M
Amount sold
$77.1M
First sale
May 2019
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedNov 2018 · 109 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank BellizziExecutive Officer, Director
  • Thomas KingExecutive Officer, Director
  • Craig HusfeldExecutive Officer
  • John DonovanExecutive Officer, Director
Offering amount
$20M
Amount sold
$20M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedDec 2017 · 79 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank BellizziExecutive Officer, Director
  • Craig HusfeldExecutive Officer
  • John DonovanExecutive Officer, Director
  • Thomas KingDirector
Offering amount
$7M
Amount sold
$5.4M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.4MraisedDec 2016 · 82 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Craig HusfeldDirector
  • John F. DonovanExecutive Officer, Director
  • Frank J. BellizziExecutive Officer
Offering amount
$9.6M
Amount sold
$8.4M
First sale
Aug 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Concentric Analgesics's investors?
Concentric Analgesics's investors include Kern Capital, LLC.
How much funding has Concentric Analgesics raised?
Concentric Analgesics has disclosed $130.8M raised across 5 rounds.
Where is Concentric Analgesics headquartered?
Concentric Analgesics is headquartered in Los Altos, US.